News & Events
-
October 25, 2016
TB-ReFLECT: A Collaborative Effort to Enhance TB Clinical Research
Oct 25, 2016 TB-ReFLECT: A Collaborative Effort to Enhance TB Clinical Research TUCSON, Ariz., October 25, 2016 — The Critical Path Institute’s Critical Path to TB Drug Regimens (CPTR) initiative and the Global TB Programme of the World Health Organization (WHO) have partnered with researchers from the University of California, San Francisco (UCSF),...... -
October 17, 2016
IMI SAFE-T and C-Path PSTC Obtain Regulatory Support for New Liver Safety Biomarkers
Oct 17, 2016 IMI SAFE-T and C-Path PSTC Obtain Regulatory Support for New Liver Safety Biomarkers US FDA and EMA Letters of Support Pave the Way for Clinical Qualification The Innovative Medicines Initiative (IMI) SAFE-T (Safer and Faster Evidence Based Translation) Consortium and Critical Path Institute (C-Path) Predictive Safety Testing Consortium (PSTC)...... -
October 10, 2016
Critical Path for Parkinson’s Consortium achieves regulatory support in Europe for use of imaging biomarker in Parkinson’s disease clinical trials
Oct 10, 2016 Critical Path for Parkinson’s Consortium achieves regulatory support in Europe for use of imaging biomarker in Parkinson’s disease clinical trials London and Tucson, Ariz., October 10, 2016 — The Critical Path Institute (C-Path), in partnership with Parkinson’s UK, announced today that the European Medicines Agency (EMA) has issued a...... -
July 13, 2016
Critical Path Institute Announces Dr. Timothy R. Franson as Chair of C-Path’s Board of Directors
July 13, 2016 Critical Path Institute Announces Dr. Timothy R. Franson as Chair of C-Path’s Board of Directors TUCSON, Ariz., July 13, 2016 — The Critical Path Institute (C-Path) is pleased to announce the appointment of Dr. Timothy R. Franson as Chair of C-Path’s Board of Directors. Franson replaces Peter B. Corr, MD,...... -
June 6, 2016
C-Path and CDISC Announce Updated Therapeutic Area Standard for TB
June 6, 2016 C-Path and CDISC Announce Updated Therapeutic Area Standard for TB TUCSON, Ariz., and AUSTIN, Texas – 6 June 2016 – The Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute (C-Path) announce the open availability of an updated CDISC Therapeutic Area (TA) Standard for tuberculosis (TB). The tuberculosis......